Cipla's Q3 FY26 Net Profit Plunges 57% to ₹674 Crore Amid Flat Revenue
Business
M
Moneycontrol•23-01-2026, 14:18
Cipla's Q3 FY26 Net Profit Plunges 57% to ₹674 Crore Amid Flat Revenue
- •Cipla reported a significant 57% year-on-year decline in consolidated net profit, settling at ₹674 crore for Q3 FY26.
- •Revenue from operations remained largely flat at ₹7,074 crore, showing a marginal increase from the previous year.
- •EBITDA decreased by 36.9% to ₹1,255 crore, with an EBITDA margin of 17.7% for the quarter.
- •Key business segments like One India, North America, One Africa, and Emerging Markets & Europe showed varied performance, with North America's Albuterol ranking #1 in the U.S. market.
- •Strategic moves include an exclusive marketing and distribution agreement with Pfizer for key brands in India and the acquisition of Inzpera Healthsciences.
Why It Matters: Cipla's Q3 FY26 saw a sharp 57% profit drop despite stable revenue, driven by lower EBITDA.
✦
More like this
Loading more articles...
